183 related articles for article (PubMed ID: 8617970)
1. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors.
Sajjadi FG; Takabayashi K; Foster AC; Domingo RC; Firestein GS
J Immunol; 1996 May; 156(9):3435-42. PubMed ID: 8617970
[TBL] [Abstract][Full Text] [Related]
2. Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors.
Hill RJ; Oleynek JJ; Hoth CF; Kiron MA; Weng W; Wester RT; Tracey WR; Knight DR; Buchholz RA; Kennedy SP
J Pharmacol Exp Ther; 1997 Jan; 280(1):122-8. PubMed ID: 8996189
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
4. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice.
Haskó G; Szabó C; Németh ZH; Kvetan V; Pastores SM; Vizi ES
J Immunol; 1996 Nov; 157(10):4634-40. PubMed ID: 8906843
[TBL] [Abstract][Full Text] [Related]
5. Adenosine inhibits tissue factor expression by LPS-stimulated human monocytes: involvement of the A3 adenosine receptor.
Broussas M; Cornillet-Lefèbvre P; Potron G; Nguyên P
Thromb Haemost; 2002 Jul; 88(1):123-30. PubMed ID: 12152652
[TBL] [Abstract][Full Text] [Related]
6. Activation of adenosine receptors inhibits tumor necrosis factor-alpha release by decreasing TNF-alpha mRNA stability and p38 activity.
Fotheringham JA; Mayne MB; Grant JA; Geiger JD
Eur J Pharmacol; 2004 Aug; 497(1):87-95. PubMed ID: 15321739
[TBL] [Abstract][Full Text] [Related]
7. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors.
Bouma MG; Jeunhomme TM; Boyle DL; Dentener MA; Voitenok NN; van den Wildenberg FA; Buurman WA
J Immunol; 1997 Jun; 158(11):5400-8. PubMed ID: 9164961
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo.
Bowlin TL; Borcherding DR; Edwards CK; McWhinney CD
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):345-9. PubMed ID: 9193789
[TBL] [Abstract][Full Text] [Related]
9. The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells.
Bshesh K; Zhao B; Spight D; Biaggioni I; Feokistov I; Denenberg A; Wong HR; Shanley TP
J Leukoc Biol; 2002 Nov; 72(5):1027-36. PubMed ID: 12429726
[TBL] [Abstract][Full Text] [Related]
10. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.
Martin L; Pingle SC; Hallam DM; Rybak LP; Ramkumar V
J Pharmacol Exp Ther; 2006 Jan; 316(1):71-8. PubMed ID: 16188954
[TBL] [Abstract][Full Text] [Related]
11. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
12. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
Wu GJ; Chen TL; Ueng YF; Chen RM
Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
[TBL] [Abstract][Full Text] [Related]
13. cDNA microarray analysis reveals a nuclear factor-kappaB-independent regulation of macrophage function by adenosine.
Németh ZH; Leibovich SJ; Deitch EA; Vizi ES; Szabó C; Hasko G
J Pharmacol Exp Ther; 2003 Sep; 306(3):1042-9. PubMed ID: 12766259
[TBL] [Abstract][Full Text] [Related]
14. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.
Jovanovic DV; Di Battista JA; Martel-Pelletier J; Jolicoeur FC; He Y; Zhang M; Mineau F; Pelletier JP
J Immunol; 1998 Apr; 160(7):3513-21. PubMed ID: 9531313
[TBL] [Abstract][Full Text] [Related]
15. Differential regulatory effects of adenosine on cytokine release by activated human monocytes.
Bouma MG; Stad RK; van den Wildenberg FA; Buurman WA
J Immunol; 1994 Nov; 153(9):4159-68. PubMed ID: 7930619
[TBL] [Abstract][Full Text] [Related]
16. Macrophage TNF mRNA expression is modulated by protease inhibitors.
Lo CJ; Fu M; Kim B
J Surg Res; 1997 May; 69(2):408-12. PubMed ID: 9224415
[TBL] [Abstract][Full Text] [Related]
17. Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression.
Xaus J; Valledor AF; Cardó M; Marquès L; Beleta J; Palacios JM; Celada A
J Immunol; 1999 Oct; 163(8):4140-9. PubMed ID: 10510349
[TBL] [Abstract][Full Text] [Related]
18. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
19. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.
Zhang JG; Hepburn L; Cruz G; Borman RA; Clark KL
Biochem Pharmacol; 2005 Mar; 69(6):883-9. PubMed ID: 15748700
[TBL] [Abstract][Full Text] [Related]
20. A food-born heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), suppresses tumor necrosis factor-alpha expression in lipoteichoic acid-stimulated RAW 264.7 cells.
Im J; Choi HS; Kim SK; Woo SS; Ryu YH; Kang SS; Yun CH; Han SH
Cancer Lett; 2009 Feb; 274(1):109-17. PubMed ID: 18845389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
